Related Experiment Video
Updated: Jan 24, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
[The efficacy of remaxol as a hepatoprotective agent in long-term psychopharmacotherapy]
N V Filippova1, Yu B Barylnik1, A A Shuldyakov1
1Razumovsky Saratov State Medical University, Saratov, Russia.
Aim:
Evaluation of the efficacy of psychopharmacotherapy with the hepatoprotector remaxol.
Material And Methods:
A study was conducted on 60 male patients diagnosed with 'Paranoid schizophrenia, continuous progression type course' who received therapy for the underlying disease with traditional antipsychotics in a psychiatric inpatient setting. During the 12 days of the study, 30 patients (main group) received neuroleptic therapy in combination with intravenous infusions of remaxol (400.0 ml), the remaining 30 patients (control group) received 'active placebo' (0.9% sodium chloride solution, 400.0 ml).
Results And Conclusion:
A decrease in the frequency and severity of astheno-vegetative, dyspeptic, hemorrhagic, cholestatic syndromes and hepatomegaly was shown. The absence of side-effects along with an improvement in the general well-being of the patients is extremely important in long-term psychopharmacotherapy of psychiatric patients.
Related Concept Videos
Self-Efficacy
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Subviral Agents
Directional Terms
Long-term Potentiation
Hebbian LTP
LTP can occur when...

